TY - JOUR
T1 - Stroke Learning Health Systems
T2 - A Topical Narrative Review With Case Examples
AU - Cadilhac, Dominique A.
AU - Bravata, Dawn M.
AU - Bettger, Janet Prvu
AU - Mikulik, Robert
AU - Norrving, Bo
AU - Uvere, Ezinne O.
AU - Owolabi, Mayowa
AU - Ranta, Annemarei
AU - Kilkenny, Monique F.
N1 - Funding Information:
Dr Cadilhac acknowledges research fellowship support from the National Health and Medical Research Council (no. 1154273). Dr Mikulik was supported by various projects: IRENE (Implementation Research Network in Stroke Care Quality; no. CA18118 European Cooperation in Science and Technology), IRIS-TEPUS (Implementation Research for Improving Stroke Care: Translation of Evidence to Patients Using Science; no. LTC20051) INTER-EXCELLENCE INTER-COST Program of the Ministry of Education, Youth, and Sports of the Czech Republic, STROCZECH (Czech Stroke Research Infrastructure Network) within Research Infrastructure grant (no. LM2018128; funded by the state budget of the Czech Republic), CARES (Comprehensive Integrated Healthcare Framework for Improving Stroke Outcomes in the Czech Republic) CZ no. NU21-09-00548 (Ministry of Health of the Czech Republic), and the INBIO (Engineering of New Biomaterials and Biopharmaceuticals for the Diagnosis and Treatment of the Cerebrovascular and Neurodegenerative Diseases; project no. CZ.02.1.01/0.0/0.0/16_026/0008451; European Regional Development Fund). Dr Norrving has received honoraria from AstraZeneca and Bayer for Data Safety Monitoring Boards for the THALES (The Acute Stroke or Transient Ischemic Attack Treated With Ticagrelor and Aspirin for Prevention of Stroke and Death) and NAVIGATE-ESUS (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs Aspirin to Prevent Embolism in Embolic Stroke of Undetermined Source) trials. Dr Owolabi is supported by National Institutes of Health grants: SIREN (Stroke Investigative Research and Educational Network; U54HG007479), SIBS Genomics (Systematic Investigation of Blacks With Stroke Using Genomics; R01NS107900), SIBS-Gen-Gen (Facilitating Implementation Science Within the SIBS Genomics Study; R01NS107900-02S1), ARISES (African Rigorous Innovative Stroke Epidemiological Surveillance; R01NS115944‐01), H3Africa CVD Supplement (Human Health and Heredity Africa Diseases Working Group; 3U24HG009780‐03S5), CaNVAS (Copy Number Variations and Stroke; 1R01NS114045-01), SSACS (Sub-Saharan Africa Conference on Stroke; 1R13NS115395-01A1) and TALENTS (Training Africans to Lead and Execute Neurological Trials & Studies; D43TW012030). Dr Ranta reports grants from the Health Research Council of New Zealand and the Ministry of Health (NZ), travel grants from University of Texas (Austin), and Virginia Commonwealth University School of Medicine (United States) unrelated to this article, employment by Capital and Coast District Health Board. Dr Kilkenny acknowledges a Future Leader Fellowship (no. 105737) from the National Heart Foundation of Australia. Dr Kilkenny is a member of the Stroke Foundation Research and Advisory Committee, and Australian Institute of Health and Welfare Cardiovascular Disease Expert Advisory Group, and is the Associate Editor of the Health Information Management Journal.
Funding Information:
Dr Cadilhac acknowledges research fellowship support from the National Health and Medical Research Council (no. 1154273). Dr Mikulik was supported by various projects: IRENE (Implementation Research Network in Stroke Care Quality; no. CA18118 European Cooperation in Science and Technology), IRIS-TEPUS (Implementation Research for Improving Stroke Care: Translation of Evidence to Patients Using Science; no. LTC20051) INTER-EXCELLENCE INTER-COST Program of the Ministry of Education, Youth, and Sports of the Czech Republic, STROCZECH (Czech Stroke Research Infrastructure Network) within Research Infrastructure grant (no. LM2018128; funded by the state budget of the Czech Republic), CARES (Comprehensive Integrated Healthcare Framework for Improving Stroke Outcomes in the Czech Republic) CZ no. NU21-09-00548 (Ministry of Health of the Czech Republic), and the INBIO (Engineering of New Biomaterials and Biopharmaceuticals for the Diagnosis and Treatment of the Cerebrovascular and Neurodegenerative Diseases; project no. CZ.02.1.01/0.0/0.0/16_026/0008451; European Regional Development Fund). Dr Norrving has received honoraria from AstraZeneca and Bayer for Data Safety Monitoring Boards for the THALES (The Acute Stroke or Transient Ischemic Attack Treated With Ticagrelor and Aspirin for Prevention of Stroke and Death) and NAVIGATE-ESUS (New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs Aspirin to Prevent Embolism in Embolic Stroke of Undetermined Source) trials. Dr Owolabi is supported by National Institutes of Health grants: SIREN (Stroke Investigative Research and Educational Network; U54HG007479), SIBS Genomics (Systematic Investigation of Blacks With Stroke Using Genomics; R01NS107900), SIBS-Gen-Gen (Facilitating Implementation Science Within the SIBS Genomics Study; R01NS107900-02S1), ARISES (African Rigorous Innovative Stroke Epidemiological Surveillance; R01NS115944‐01), H3Africa CVD Supplement (Human Health and Heredity Africa Diseases Working Group; 3U24HG009780‐03S5), CaNVAS (Copy Number Variations and Stroke; 1R01NS114045-01), SSACS (Sub-Saharan Africa Conference on Stroke; 1R13NS115395-01A1) and TALENTS (Training Africans to Lead and Execute Neurological Trials & Studies; D43TW012030). Dr Ranta reports grants from the Health Research Council of New Zealand and the Ministry of Health (NZ), travel grants from University of Texas (Austin), and Virginia Commonwealth University School of Medicine (United States) unrelated to this article, employment by Capital and Coast District Health Board. Dr Kilkenny acknowledges a Future Leader Fellowship (no. 105737) from the National Heart Foundation of Australia. Dr Kilkenny is a member of the Stroke Foundation Research and Advisory Committee, and Australian Institute of Health and Welfare Cardiovascular Disease Expert Advisory Group, and is the Associate Editor of the Health Information Management Journal.
Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/4/1
Y1 - 2023/4/1
N2 - To our knowledge, the adoption of Learning Health System (LHS) concepts or approaches for improving stroke care, patient outcomes, and value have not previously been summarized. This topical review provides a summary of the published evidence about LHSs applied to stroke, and case examples applied to different aspects of stroke care from high and low-to-middle income countries. Our attempt to systematically identify the relevant literature and obtain real-world examples demonstrated the dissemination gaps, the lack of learning and action for many of the related LHS concepts across the continuum of care but also elucidated the opportunity for continued dialogue on how to study and scale LHS advances. In the field of stroke, we found only a few published examples of LHSs and health systems globally implementing some selected LHS concepts, but the term is not common. A major barrier to identifying relevant LHS examples in stroke may be the lack of an agreed taxonomy or terminology for classification. We acknowledge that health service delivery settings that leverage many of the LHS concepts do so operationally and the lessons learned are not shared in peer-reviewed literature. It is likely that this topical review will further stimulate the stroke community to disseminate related activities and use keywords such as learning health system so that the evidence base can be more readily identified.
AB - To our knowledge, the adoption of Learning Health System (LHS) concepts or approaches for improving stroke care, patient outcomes, and value have not previously been summarized. This topical review provides a summary of the published evidence about LHSs applied to stroke, and case examples applied to different aspects of stroke care from high and low-to-middle income countries. Our attempt to systematically identify the relevant literature and obtain real-world examples demonstrated the dissemination gaps, the lack of learning and action for many of the related LHS concepts across the continuum of care but also elucidated the opportunity for continued dialogue on how to study and scale LHS advances. In the field of stroke, we found only a few published examples of LHSs and health systems globally implementing some selected LHS concepts, but the term is not common. A major barrier to identifying relevant LHS examples in stroke may be the lack of an agreed taxonomy or terminology for classification. We acknowledge that health service delivery settings that leverage many of the LHS concepts do so operationally and the lessons learned are not shared in peer-reviewed literature. It is likely that this topical review will further stimulate the stroke community to disseminate related activities and use keywords such as learning health system so that the evidence base can be more readily identified.
KW - emergency medical services
KW - ischemic attack, transient
KW - learning health system
KW - quality improvement
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85151045090&partnerID=8YFLogxK
U2 - 10.1161/STROKEAHA.122.036216
DO - 10.1161/STROKEAHA.122.036216
M3 - Review Article
C2 - 36715006
AN - SCOPUS:85151045090
SN - 0039-2499
VL - 54
SP - 1148
EP - 1159
JO - Stroke
JF - Stroke
IS - 4
ER -